Humacyte, Inc.

Alpha Healthcare Acquisition Corp. III, listed on Nasdaq under the ticker AHAC, was a blank-check company sponsored by Alpha Healthcare Advisors and managed by Roderick Wong. The SPAC completed its initial public offering in 2021, targeting the healthcare and life sciences sector. On September 17, 2021, it filed an S-1 registration statement in connection with its proposed merger with Humacyte, Inc., a clinical-stage regenerative medicine company developing bioengineered human acellular vessels intended for vascular repair and reconstruction. The transaction brought Humacyte to public markets, with shares subsequently trading under the ticker HUMA on Nasdaq. Sign up at SpacDesk for complete filing history, deal analytics, and comprehensive SPAC data coverage.